Key Takeaways
- Bank of America maintains its Buy recommendation on NVDA with a $350 price objective, suggesting 78% potential gains
- NVDA has climbed only 4% this year while the SOX semiconductor index has rallied nearly 72%
- BofA analyst Vivek Arya believes worries about memory expenses and custom chip rivals are exaggerated
- GPU accelerator revenue has expanded 700-fold since application-specific integrated circuits emerged in 2015
- The firm views the coming quarterly report as a key moment that could reverse negative sentiment
While Nvidia has posted modest 4% gains through 2026, the Philadelphia Semiconductor Index has rocketed nearly 72% higher. This performance disparity stands out for a chipmaker that continues to lead the AI computing infrastructure market.
Vivek Arya, a Bank of America analyst ranked among Wall Street’s top 2%, believes this lag represents a mispricing rather than fundamental weakness. He’s backing his conviction with a $350 valuation target on NVDA shares. With the stock hovering near $197, this projection implies approximately 78% appreciation potential.
Arya identifies four primary headwinds pressuring the stock: declining gross profit margins due to elevated memory component costs, threats from custom silicon solutions, concentrated institutional positioning, and inefficient capital deployment through vendor financing arrangements.
His assessment? These worries are either blown out of proportion or fundamentally misinterpreted.
Regarding memory component expenses, Arya notes that while HBM costs per rack may increase by $0.2–0.3 million in the transition from Blackwell to Rubin platforms, complete rack pricing could jump $2–3 million — escalating from approximately $3–4 million to $6–7 million. This pricing authority, he contends, should preserve gross profit margins around the mid-70% threshold.
Custom Silicon Has Coexisted With GPU Dominance
The application-specific chip challenge is genuine, but it’s hardly unprecedented. Google introduced its Tensor Processing Unit nearly a decade ago in 2015. Amazon entered the arena with Trainium chips in 2020. Meta launched MTIA in 2023. Despite these developments, Nvidia’s GPU accelerator revenue expanded 700-fold during this period.
Recent divisional results reveal that hyperscaler revenue jumped 115% year-over-year — outpacing cloud capital expenditure growth by roughly 2x. According to Arya, this demonstrates market share expansion rather than erosion.
The fundamental distinction between GPUs and application-specific chips, he emphasizes, lies in versatility. Custom silicon serves narrow workloads within individual cloud provider infrastructures. Nvidia delivers a comprehensive platform with universal compatibility. Arya projects Nvidia will command 65–70% of AI infrastructure spending over the long term, with the remaining 30–35% distributed among custom chips and competitors like AMD.
Concerning shareholder composition, approximately 78% of active S&P 500 funds maintain NVDA positions, with 1.15x relative weighting. Strategic equity investments total roughly $65 billion. While Arya recognizes these as potential obstacles, he calculates the investments absorb under 35% of operating cash flow, preserving capacity for share repurchases and dividend payments.
Quarterly Report Could Shift Market Sentiment
Arya identifies the approaching earnings announcement as a potential inflection point for investor perception. He anticipates it will “reinforce Nvidia’s competitive advantages in technology, pricing power, and logistics capabilities.”
At present valuations, NVDA commands an 18x forward earnings multiple — representing a seven-year trough. Comparable large-cap technology companies — Amazon, Meta, Google, Microsoft, Apple — average 22x–19x forward multiples based on CY27/28 projections. That represents a 30–35% valuation premium versus Nvidia, which Arya characterizes as unreasonable considering comparative growth trajectories.
Wall Street consensus aligns with this optimistic view. Among 37 analyst opinions, 36 recommend buying while one rates it a hold. The consensus 12-month price objective stands at $309.33, implying 57% appreciation from current levels.


